Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
171.00    2.60 (1.54%)
Bid:
171.20
Ask:
171.80
Spread: 0.60 (0.35%)
Market Cap: £416.08m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Director/PDMR Shareholding Replacement

22 Apr 2021 10:00

RNS Number : 3067W
Sabre Insurance Group PLC
22 April 2021
 

22 April 2021

 

Sabre Insurance Group plc ("Sabre" or the "Company")

Notification of transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

Sabre announces that on 21 April 2021, the following Directors and PDMRs of the Company were each granted an option under the Sabre 2017 Sharesave Plan (the "Plan") over ordinary shares of £0.001 in the Company as detailed below:

 

Name

Position

No of shares subject to option

Option Price

Bonus Date

Geoff Carter

Chief Executive Officer

4,680

£1.923

1 July 2024

Trevor Webb

Claims Director

 

4,680

£1.923

1 July 2024

Adam Westwood

Chief Financial Officer

9,360

£1.923

1 July 2024

Matt Wright

Chief Actuary

4,680

 

£1.923

1 July 2024

 

Subject to the terms of the Plan, the options will vest on the Bonus Date and be exercisable for a period of six months, subject to continued service with the Company.

 

This notification is made pursuant to Article 19 of the EU Market Abuse Regulation.

 

Additional Information:

Anneka Kingan - Company Secretary

Anneka.kingan@sabre.co.uk 

 

 

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Geoff Carter

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable option over ordinary shares in the Company under the Sabre 2017 Sharesave Plan ('the Option')

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

Grant of option

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£1.923

4,680

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

4,680

£1.923

 

e)

Date of transaction

21 April 2020

f)

Place of transaction

London Stock Exchange (XLON)

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Trevor Webb

2

 

Reason for the notification

 

a)

 

Position/status

 

Claims Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable option over ordinary shares in the Company under the Sabre 2017 Sharesave Plan ('the Option')

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

Grant of option

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£1.923

4,680

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

4,680

£1.923

 

e)

Date of transaction

21 April 2020

f)

Place of transaction

London Stock Exchange (XLON)

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Adam Westwood

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable option over ordinary shares in the Company under the Sabre 2017 Sharesave Plan ('the Option')

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

Grant of option

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£1.923

9,360

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

9,360

£1.923

 

e)

Date of transaction

21 April 2020

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Matt Wright

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Actuary

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable option over ordinary shares in the Company under the Sabre 2017 Sharesave Plan ('the Option')

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

Grant of option

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£1.923

4,680

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

4,680

£1.923

 

e)

Date of transaction

21 April 2020

f)

Place of transaction

London Stock Exchange (XLON)

 

Additional Information:

Anneka Kingan - Company Secretary

Anneka.kingan@sabre.co.uk 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZGZDRZRGMZG
Date   Source Headline
11th Jul 20232:57 pmRNSDirector/PDMR Shareholding
13th Jun 202310:09 amRNSDirector/PDMR Shareholding
2nd Jun 20233:02 pmRNSDirector/PDMR Shareholding
25th May 202311:22 amRNSResult of AGM
25th May 20239:27 amRNSDirector/PDMR Shareholding
25th May 20237:01 amRNSBoard Appointment
25th May 20237:00 amRNSTrading Update
11th May 202311:42 amRNSDirector/PDMR Shareholding
18th Apr 20233:19 pmRNSDirector/PDMR Shareholding
12th Apr 202311:53 amRNSDirector/PDMR Shareholding
6th Apr 202312:28 pmRNSDirector/PDMR Shareholding
31st Mar 20233:43 pmRNSNotice of AGM
31st Mar 20233:37 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSFinal Results
13th Mar 202312:13 pmRNSDirector/PDMR Shareholding
13th Feb 20231:51 pmRNSDirector/PDMR Shareholding
13th Jan 20231:52 pmRNSHolding(s) in Company
11th Jan 20234:00 pmRNSDirector/PDMR Shareholding
19th Dec 20222:31 pmRNSHolding(s) in Company
13th Dec 20221:20 pmRNSDirector/PDMR Shareholding
11th Nov 202212:09 pmRNSDirector/PDMR Shareholding
7th Nov 20221:47 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
11th Oct 20223:20 pmRNSDirector/PDMR Shareholding
28th Sep 20222:11 pmRNSDirector/PDMR Shareholding
23rd Sep 202211:47 amRNSDirector/PDMR Shareholding
13th Sep 20223:57 pmRNSDirector/PDMR Shareholding
26th Aug 202210:45 amRNSDirectorate Change
11th Aug 20223:25 pmRNSDirector/PDMR Shareholding
10th Aug 20229:08 amRNSHolding(s) in Company
1st Aug 20229:19 amRNSDirector/PDMR Shareholding
28th Jul 20222:34 pmRNSHolding(s) in Company
28th Jul 20229:14 amRNSHolding(s) in Company
27th Jul 20221:35 pmRNSDirector/PDMR Shareholding
27th Jul 20229:26 amRNSHolding(s) in Company
27th Jul 20229:19 amRNSDirector/PDMR Shareholding
26th Jul 202212:19 pmRNSDirector/PDMR Shareholding
26th Jul 202212:06 pmRNSDirector/PDMR Shareholding
26th Jul 20227:00 amRNSHalf-Year Report 2022
18th Jul 20221:07 pmRNSHolding(s) in Company
14th Jul 20227:00 amRNSHalf-Year 2022 Trading Update
12th Jul 202212:49 pmRNSDirector/PDMR Shareholding
1st Jul 20229:55 amRNSHolding(s) in Company
14th Jun 202211:58 amRNSDirector/PDMR Shareholding
13th Jun 20223:54 pmRNSDirector/PDMR Shareholding
6th Jun 20223:15 pmRNSDirector/PDMR Shareholding
6th Jun 20223:06 pmRNSDirector/PDMR Shareholding
25th May 20221:24 pmRNSResult of AGM
25th May 20227:00 amRNSTrading Update
19th May 20221:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.